{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:11:52Z","timestamp":1793938312401,"version":"4.8.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"State of Texas Rare and Aggressive Breast Cancer Research Program grant"},{"name":"National Institutes of Health\/National Cancer Institute award","award":["1R01CA205043-01A1"],"award-info":[{"award-number":["1R01CA205043-01A1"]}]},{"name":"Harry E. Bovay, Jr. Foundation gift"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10549-020-06092-5","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T11:03:31Z","timestamp":1611227011000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Body composition and breast cancer risk and treatment: mechanisms and impact"],"prefix":"10.1007","volume":"186","author":[{"given":"Toshiaki","family":"Iwase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushaar Vishal","family":"Shrimanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail G.","family":"Kolonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-7275","authenticated-orcid":false,"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"issue":"5","key":"6092_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3322\/caac.21405","volume":"67","author":"M Picon-Ruiz","year":"2017","unstructured":"Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM (2017) Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin 67(5):378\u2013397. https:\/\/doi.org\/10.3322\/caac.21405","journal-title":"CA Cancer J Clin"},{"key":"6092_CR2","unstructured":"Statistics NCfH (2020) FastStats disability and risk factors-obesity and overweight. https:\/\/www.cdc.gov\/nchs\/fastats\/obesity-overweight.htm"},{"issue":"21","key":"6092_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1001\/jama.2016.6458","volume":"315","author":"KM Flegal","year":"2016","unstructured":"Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315(21):2284\u20132291. https:\/\/doi.org\/10.1001\/jama.2016.6458","journal-title":"JAMA"},{"issue":"9612","key":"6092_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0140-6736(08)60269-x","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (London, England) 371(9612):569\u2013578. https:\/\/doi.org\/10.1016\/s0140-6736(08)60269-x","journal-title":"Lancet (London, England)"},{"issue":"1","key":"6092_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10549-015-3287-5","volume":"150","author":"C Fontanella","year":"2015","unstructured":"Fontanella C, Lederer B, Gade S, Vanoppen M, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Gerber B, Hanusch C, Hilfrich J, Huober J, Schneeweiss A, Paepke S, Jackisch C, Mehta K, Nekljudova V, Untch M, Neven P, von Minckwitz G, Loibl S (2015) Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials. Breast Cancer Res Treat 150(1):127\u2013139. https:\/\/doi.org\/10.1007\/s10549-015-3287-5","journal-title":"Breast Cancer Res Treat"},{"issue":"25","key":"6092_CR6","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1200\/jco.2007.14.4527","volume":"26","author":"JK Litton","year":"2008","unstructured":"Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM (2008) Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26(25):4072\u20134077. https:\/\/doi.org\/10.1200\/jco.2007.14.4527","journal-title":"J Clin Oncol"},{"issue":"6","key":"6092_CR7","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1186\/bcr3572","volume":"15","author":"B Pajares","year":"2013","unstructured":"Pajares B, Pollan M, Martin M, Mackey JR, Lluch A, Gavila J, Vogel C, Ruiz-Borrego M, Calvo L, Pienkowski T, Rodriguez-Lescure A, Segui MA, Tredan O, Anton A, Ramos M, Camara Mdel C, Rodriguez-Martin C, Carrasco E, Alba E (2013) Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis. Breast Cancer Res 15(6):R105. https:\/\/doi.org\/10.1186\/bcr3572","journal-title":"Breast Cancer Res"},{"issue":"3","key":"6092_CR8","doi-asserted-by":"publisher","first-page":"E506","DOI":"10.1152\/ajpendo.00586.2009","volume":"299","author":"N Kloting","year":"2010","unstructured":"Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, Stumvoll M, Bluher M (2010) Insulin-sensitive obesity. Am J Phys Endocrinol Metab 299(3):E506\u2013E515. https:\/\/doi.org\/10.1152\/ajpendo.00586.2009","journal-title":"Am J Phys Endocrinol Metab"},{"issue":"Suppl 2","key":"6092_CR9","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.2337\/dcS13-2023","volume":"36","author":"V Hainer","year":"2013","unstructured":"Hainer V, Aldhoon-Hainerova I (2013) Obesity paradox does exist. Diabetes Care 36(Suppl 2):S276\u2013S281. https:\/\/doi.org\/10.2337\/dcS13-2023","journal-title":"Diabetes Care"},{"issue":"6","key":"6092_CR10","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1210\/en.2009-0070","volume":"150","author":"MP Cleary","year":"2009","unstructured":"Cleary MP, Grossmann ME (2009) Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 150(6):2537\u20132542. https:\/\/doi.org\/10.1210\/en.2009-0070","journal-title":"Endocrinology"},{"issue":"6","key":"6092_CR11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ijo.2008.25","volume":"32","author":"JC Lovejoy","year":"2008","unstructured":"Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR (2008) Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 32(6):949\u2013958. https:\/\/doi.org\/10.1038\/ijo.2008.25","journal-title":"Int J Obes"},{"issue":"5","key":"6092_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/oby.2011.383","volume":"20","author":"S Liedtke","year":"2012","unstructured":"Liedtke S, Schmidt ME, Vrieling A, Lukanova A, Becker S, Kaaks R, Zaineddin AK, Buck K, Benner A, Chang-Claude J, Steindorf K (2012) Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring, Md) 20(5):1088\u20131095. https:\/\/doi.org\/10.1038\/oby.2011.383","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"2","key":"6092_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1055-9965.epi-09-0532","volume":"19","author":"L Baglietto","year":"2010","unstructured":"Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD, Giles GG (2010) Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 19(2):492\u2013502. https:\/\/doi.org\/10.1158\/1055-9965.epi-09-0532","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"20","key":"6092_CR14","first-page":"7488","volume":"61","author":"JA Lavigne","year":"2001","unstructured":"Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, Yager JD (2001) The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res 61(20):7488\u20137494","journal-title":"Cancer Res"},{"issue":"2","key":"6092_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/carcin\/bgg191","volume":"25","author":"KM Li","year":"2004","unstructured":"Li KM, Todorovic R, Devanesan P, Higginbotham S, Kofeler H, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25(2):289\u2013297. https:\/\/doi.org\/10.1093\/carcin\/bgg191","journal-title":"Carcinogenesis"},{"issue":"4","key":"6092_CR16","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr3453","volume":"15","author":"LW Bowers","year":"2013","unstructured":"Bowers LW, Cavazos DA, Maximo IX, Brenner AJ, Hursting SD, deGraffenried LA (2013) Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K\/Akt and MAPK pathways to promote in vitro measures of breast cancer progression. Breast Cancer Res 15(4):R59. https:\/\/doi.org\/10.1186\/bcr3453","journal-title":"Breast Cancer Res"},{"issue":"3","key":"6092_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJMra050776","volume":"354","author":"JD Yager","year":"2006","unstructured":"Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354(3):270\u2013282. https:\/\/doi.org\/10.1056\/NEJMra050776","journal-title":"N Engl J Med"},{"issue":"2","key":"6092_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3892\/ijo.2012.1480","volume":"41","author":"M Weichhaus","year":"2012","unstructured":"Weichhaus M, Broom J, Wahle K, Bermano G (2012) A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer. Int J Oncol 41(2):745\u2013752. https:\/\/doi.org\/10.3892\/ijo.2012.1480","journal-title":"Int J Oncol"},{"issue":"2","key":"6092_CR19","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.1152\/ajpendo.00203.2004","volume":"288","author":"M Kabir","year":"2005","unstructured":"Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN (2005) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288(2):E454\u2013E461. https:\/\/doi.org\/10.1152\/ajpendo.00203.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"6092_CR20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915\u2013928. https:\/\/doi.org\/10.1038\/nrc2536","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"6092_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1200\/jco.1999.17.1.120","volume":"17","author":"PJ Goodwin","year":"1999","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, Trudeau M, Hood N, Redwood S (1999) Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17(1):120\u2013129. https:\/\/doi.org\/10.1200\/jco.1999.17.1.120","journal-title":"J Clin Oncol"},{"issue":"11","key":"6092_CR22","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/gme.0b013e31821b849b","volume":"18","author":"AM Gordon","year":"2011","unstructured":"Gordon AM, Hurwitz S, Shapiro CL, LeBoff MS (2011) Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer. Menopause (New York, NY) 18(11):1244\u20131248. https:\/\/doi.org\/10.1097\/gme.0b013e31821b849b","journal-title":"Menopause (New York, NY)"},{"issue":"5","key":"6092_CR23","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1210\/jc.2003-031874","volume":"89","author":"RJ Freedman","year":"2004","unstructured":"Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, Hill S, Sebring N, Reynolds JC, Yanovski JA (2004) Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab 89(5):2248\u20132253. https:\/\/doi.org\/10.1210\/jc.2003-031874","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6092_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00280-016-3045-3","volume":"78","author":"JC Sorensen","year":"2016","unstructured":"Sorensen JC, Cheregi BD, Timpani CA, Nurgali K, Hayes A, Rybalka E (2016) Mitochondria: inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting? Cancer Chemother Pharmacol 78(4):673\u2013683. https:\/\/doi.org\/10.1007\/s00280-016-3045-3","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"6092_CR25","doi-asserted-by":"publisher","first-page":"R337","DOI":"10.1152\/ajpregu.00469.2004","volume":"288","author":"SK Powers","year":"2005","unstructured":"Powers SK, Kavazis AN, DeRuisseau KC (2005) Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 288(2):R337\u2013R344. https:\/\/doi.org\/10.1152\/ajpregu.00469.2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"51","key":"6092_CR26","doi-asserted-by":"publisher","first-page":"19709","DOI":"10.1074\/jbc.RA119.008426","volume":"294","author":"MD Tarpey","year":"2019","unstructured":"Tarpey MD, Amorese AJ, Balestrieri NP, Fisher-Wellman KH, Spangenburg EE (2019) Doxorubicin causes lesions in the electron transport system of skeletal muscle mitochondria that are associated with a loss of contractile function. J Biol Chem 294(51):19709\u201319722. https:\/\/doi.org\/10.1074\/jbc.RA119.008426","journal-title":"J Biol Chem"},{"issue":"8","key":"6092_CR27","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1158\/1078-0432.ccr-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15(8):2920\u20132926. https:\/\/doi.org\/10.1158\/1078-0432.ccr-08-2242","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6092_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00280-010-1288-y","volume":"67","author":"CM Prado","year":"2011","unstructured":"Prado CM, Lima IS, Baracos VE, Bies RR, McCargar LJ, Reiman T, Mackey JR, Kuzma M, Damaraju VL, Sawyer MB (2011) An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemother Pharmacol 67(1):93\u2013101. https:\/\/doi.org\/10.1007\/s00280-010-1288-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"6092_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10549-012-2085-6","volume":"134","author":"I Sestak","year":"2012","unstructured":"Sestak I, Harvie M, Howell A, Forbes JF, Dowsett M, Cuzick J (2012) Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer. Breast Cancer Res Treat 134(2):727\u2013734. https:\/\/doi.org\/10.1007\/s10549-012-2085-6","journal-title":"Breast Cancer Res Treat"},{"issue":"9762","key":"6092_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0140-6736(10)62312-4","volume":"377","author":"CJ van de Velde","year":"2011","unstructured":"van de Velde CJ, Rea D, Seynaeve C, Putter H, Hasenburg A, Vannetzel JM, Paridaens R, Markopoulos C, Hozumi Y, Hille ET, Kieback DG, Asmar L, Smeets J, Nortier JW, Hadji P, Bartlett JM, Jones SE (2011) Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. Lancet (London, England) 377(9762):321\u2013331. https:\/\/doi.org\/10.1016\/s0140-6736(10)62312-4","journal-title":"Lancet (London, England)"},{"issue":"5","key":"6092_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.clbc.2014.02.003","volume":"14","author":"S Battisti","year":"2014","unstructured":"Battisti S, Guida FM, Coppa F, Vaccaro DM, Santini D, Tonini G, Zobel BB, Semelka RC (2014) Modification of abdominal fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D computed tomography volumetry. Clin Breast Cancer 14(5):365\u2013370. https:\/\/doi.org\/10.1016\/j.clbc.2014.02.003","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"6092_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.bjc.6603258","volume":"95","author":"G Francini","year":"2006","unstructured":"Francini G, Petrioli R, Montagnani A, Cadirni A, Campagna S, Francini E, Gonnelli S (2006) Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Br J Cancer 95(2):153\u2013158. https:\/\/doi.org\/10.1038\/sj.bjc.6603258","journal-title":"Br J Cancer"},{"issue":"2","key":"6092_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10549-010-1223-2","volume":"125","author":"GJ van Londen","year":"2011","unstructured":"van Londen GJ, Perera S, Vujevich K, Rastogi P, Lembersky B, Brufsky A, Vogel V, Greenspan SL (2011) The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. Breast Cancer Res Treat 125(2):441\u2013446. https:\/\/doi.org\/10.1007\/s10549-010-1223-2","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"6092_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1079\/PNS200194","volume":"60","author":"P Trayhurn","year":"2001","unstructured":"Trayhurn P, Beattie JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60(3):329\u2013339","journal-title":"Proc Nutr Soc"},{"issue":"6","key":"6092_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/10408363.2015.1041582","volume":"52","author":"S Laforest","year":"2015","unstructured":"Laforest S, Labrecque J, Michaud A, Cianflone K, Tchernof A (2015) Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Crit Rev Clin Lab Sci 52(6):301\u2013313. https:\/\/doi.org\/10.3109\/10408363.2015.1041582","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"6","key":"6092_CR36","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/jci45887","volume":"121","author":"K Sun","year":"2011","unstructured":"Sun K, Kusminski CM, Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121(6):2094\u20132101. https:\/\/doi.org\/10.1172\/jci45887","journal-title":"J Clin Invest"},{"issue":"6","key":"6092_CR37","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2014.05.012","volume":"157","author":"YS Lee","year":"2014","unstructured":"Lee YS, Kim JW, Osborne O, Oh DY, Sasik R, Schenk S, Chen A, Chung H, Murphy A, Watkins SM, Quehenberger O, Johnson RS, Olefsky JM (2014) Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell 157(6):1339\u20131352. https:\/\/doi.org\/10.1016\/j.cell.2014.05.012","journal-title":"Cell"},{"issue":"16","key":"6092_CR38","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1128\/mcb.00192-09","volume":"29","author":"N Halberg","year":"2009","unstructured":"Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE (2009) Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29(16):4467\u20134483. https:\/\/doi.org\/10.1128\/mcb.00192-09","journal-title":"Mol Cell Biol"},{"issue":"1","key":"6092_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12967-016-0962-1","volume":"14","author":"I Kralova Lesna","year":"2016","unstructured":"Kralova Lesna I, Kralova A, Cejkova S, Fronek J, Petras M, Sekerkova A, Thieme F, Janousek L, Poledne R (2016) Characterisation and comparison of adipose tissue macrophages from human subcutaneous, visceral and perivascular adipose tissue. J Transl Med 14(1):208. https:\/\/doi.org\/10.1186\/s12967-016-0962-1","journal-title":"J Transl Med"},{"issue":"5","key":"6092_CR40","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/oby.20642","volume":"22","author":"JA Deiuliis","year":"2014","unstructured":"Deiuliis JA, Oghumu S, Duggineni D, Zhong J, Rutsky J, Banerjee A, Needleman B, Mikami D, Narula V, Hazey J, Satoskar AR, Rajagopalan S (2014) CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance. Obesity (Silver Spring, Md) 22(5):1264\u20131274. https:\/\/doi.org\/10.1002\/oby.20642","journal-title":"Obesity (Silver Spring, Md)"},{"key":"6092_CR41","doi-asserted-by":"publisher","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2018) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afy169","DOI":"10.1093\/ageing\/afy169"},{"issue":"39","key":"6092_CR42","doi-asserted-by":"publisher","first-page":"25714","DOI":"10.18632\/oncotarget.25394","volume":"9","author":"F Mazzuca","year":"2018","unstructured":"Mazzuca F, Onesti CE, Roberto M, Di Girolamo M, Botticelli A, Begini P, Strigari L, Marchetti P, Muscaritoli M (2018) Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines. Oncotarget 9(39):25714\u201325722. https:\/\/doi.org\/10.18632\/oncotarget.25394","journal-title":"Oncotarget"},{"issue":"2","key":"6092_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jcsm.12165","volume":"8","author":"O Klassen","year":"2017","unstructured":"Klassen O, Schmidt ME, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, Wiskemann J (2017) Muscle strength in breast cancer patients receiving different treatment regimes. J Cachexia Sarcopenia Muscle 8(2):305\u2013316. https:\/\/doi.org\/10.1002\/jcsm.12165","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"6092_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11764-012-0234-x","volume":"6","author":"A Villasenor","year":"2012","unstructured":"Villasenor A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML (2012) Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv 6(4):398\u2013406. https:\/\/doi.org\/10.1007\/s11764-012-0234-x","journal-title":"J Cancer Surviv"},{"issue":"3","key":"6092_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12603-012-0434-0","volume":"17","author":"VE Arango-Lopera","year":"2013","unstructured":"Arango-Lopera VE, Arroyo P, Gutierrez-Robledo LM, Perez-Zepeda MU, Cesari M (2013) Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging 17(3):259\u2013262. https:\/\/doi.org\/10.1007\/s12603-012-0434-0","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"6092_CR46","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.clnu.2016.03.028","volume":"35","author":"JA Batsis","year":"2016","unstructured":"Batsis JA, Mackenzie TA, Jones JD, Lopez-Jimenez F, Bartels SJ (2016) Sarcopenia, sarcopenic obesity and inflammation: results from the 1999\u20132004 National Health and Nutrition Examination Survey. Clin Nutr (Edinburgh, Scotland) 35(6):1472\u20131483. https:\/\/doi.org\/10.1016\/j.clnu.2016.03.028","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"1","key":"6092_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40001-017-0266-9","volume":"22","author":"AL Bian","year":"2017","unstructured":"Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ (2017) A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-alpha. Eur J Med Res 22(1):25. https:\/\/doi.org\/10.1186\/s40001-017-0266-9","journal-title":"Eur J Med Res"},{"issue":"Suppl 1","key":"6092_CR48","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4\u2013S9. https:\/\/doi.org\/10.1093\/gerona\/glu057","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"6092_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MCO.0b013e32834dd297","volume":"15","author":"I Beyer","year":"2012","unstructured":"Beyer I, Mets T, Bautmans I (2012) Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 15(1):12\u201322. https:\/\/doi.org\/10.1097\/MCO.0b013e32834dd297","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7","key":"6092_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629\u2013635. https:\/\/doi.org\/10.1016\/s1470-2045(08)70153-0","journal-title":"Lancet Oncol"},{"issue":"11","key":"6092_CR51","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ncb1101-1009","volume":"3","author":"C Rommel","year":"2001","unstructured":"Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways. Nat Cell Biol 3(11):1009\u20131013. https:\/\/doi.org\/10.1038\/ncb1101-1009","journal-title":"Nat Cell Biol"},{"issue":"4","key":"6092_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/jci10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106(4):473\u2013481. https:\/\/doi.org\/10.1172\/jci10842","journal-title":"J Clin Invest"},{"issue":"5","key":"6092_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010805","volume":"5","author":"P Srikanthan","year":"2010","unstructured":"Srikanthan P, Hevener AL, Karlamangla AS (2010) Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 5(5):e10805. https:\/\/doi.org\/10.1371\/journal.pone.0010805","journal-title":"PLoS One"},{"issue":"5","key":"6092_CR54","doi-asserted-by":"publisher","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","volume":"57","author":"M Visser","year":"2002","unstructured":"Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57(5):M326\u2013M332","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"6092_CR55","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jcb.23420","volume":"113","author":"N Al-Shanti","year":"2012","unstructured":"Al-Shanti N, Stewart CE (2012) Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3. J Cell Biochem 113(3):923\u2013933. https:\/\/doi.org\/10.1002\/jcb.23420","journal-title":"J Cell Biochem"},{"issue":"2","key":"6092_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1152\/japplphysiol.00006.2008","volume":"105","author":"CP Lambert","year":"2008","unstructured":"Lambert CP, Wright NR, Finck BN, Villareal DT (2008) Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. J Appl Physiol 105(2):473\u2013478. https:\/\/doi.org\/10.1152\/japplphysiol.00006.2008","journal-title":"J Appl Physiol"},{"issue":"2","key":"6092_CR57","first-page":"126","volume":"100","author":"CJ Caspersen","year":"1985","unstructured":"Caspersen CJ, Powell KE, Christenson GM (1985) Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100(2):126\u2013131","journal-title":"Public Health Rep"},{"issue":"18","key":"6092_CR58","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.Can-16-3125","volume":"77","author":"C Dethlefsen","year":"2017","unstructured":"Dethlefsen C, Hansen LS, Lillelund C, Andersen C, Gehl J, Christensen JF, Pedersen BK, Hojman P (2017) Exercise-induced catecholamines activate the Hippo tumor suppressor pathway to reduce risks of breast cancer development. Cancer Res 77(18):4894\u20134904. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-3125","journal-title":"Cancer Res"},{"issue":"8","key":"6092_CR59","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1158\/1055-9965.epi-15-1087","volume":"25","author":"K Sturgeon","year":"2016","unstructured":"Sturgeon K, Digiovanni L, Good J, Salvatore D, Fenderson D, Domchek S, Stopfer J, Galantino ML, Bryan C, Hwang WT, Schmitz K (2016) Exercise-induced dose-response alterations in adiponectin and leptin levels are dependent on body fat changes in women at risk for breast cancer. Cancer Epidemiol Biomarkers Prev 25(8):1195\u20131200. https:\/\/doi.org\/10.1158\/1055-9965.epi-15-1087","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"6092_CR60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1200\/jco.2007.12.7357","volume":"26","author":"JA Ligibel","year":"2008","unstructured":"Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP (2008) Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 26(6):907\u2013912. https:\/\/doi.org\/10.1200\/jco.2007.12.7357","journal-title":"J Clin Oncol"},{"issue":"9","key":"6092_CR61","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1200\/jco.2017.75.7526","volume":"36","author":"CM Dieli-Conwright","year":"2018","unstructured":"Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Buchanan TA, Spicer DV, Tripathy D, Bernstein L, Mortimer JE (2018) Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: a randomized controlled trial. J Clin Oncol 36(9):875\u2013883. https:\/\/doi.org\/10.1200\/jco.2017.75.7526","journal-title":"J Clin Oncol"},{"issue":"1","key":"6092_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10549-017-4576-y","volume":"168","author":"CM Dieli-Conwright","year":"2018","unstructured":"Dieli-Conwright CM, Parmentier JH, Sami N, Lee K, Spicer D, Mack WJ, Sattler F, Mittelman SD (2018) Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention. Breast Cancer Res Treat 168(1):147\u2013157. https:\/\/doi.org\/10.1007\/s10549-017-4576-y","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"6092_CR63","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1158\/0008-5472.can-15-3307","volume":"76","author":"LW Jones","year":"2016","unstructured":"Jones LW, Kwan ML, Weltzien E, Chandarlapaty S, Sternfeld B, Sweeney C, Bernard PS, Castillo A, Habel LA, Kroenke CH, Langholz BM, Queensberry CP Jr, Dang C, Weigelt B, Kushi LH, Caan BJ (2016) Exercise and prognosis on the basis of clinicopathologic and molecular features in early-stage breast cancer: the LACE and pathways studies. Cancer Res 76(18):5415\u20135422. https:\/\/doi.org\/10.1158\/0008-5472.can-15-3307","journal-title":"Cancer Res"},{"issue":"9","key":"6092_CR64","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/bjc.2014.466","volume":"111","author":"KS Courneya","year":"2014","unstructured":"Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Vallerand JR, Adams SC, Proulx C, Dolan LB, Wooding E, Segal RJ (2014) Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy. Br J Cancer 111(9):1718\u20131725. https:\/\/doi.org\/10.1038\/bjc.2014.466","journal-title":"Br J Cancer"},{"issue":"3","key":"6092_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10549-016-3900-2","volume":"158","author":"SC Adams","year":"2016","unstructured":"Adams SC, Segal RJ, McKenzie DC, Vallerand JR, Morielli AR, Mackey JR, Gelmon K, Friedenreich CM, Reid RD, Courneya KS (2016) Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. Breast Cancer Res Treat 158(3):497\u2013507. https:\/\/doi.org\/10.1007\/s10549-016-3900-2","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"6092_CR66","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1001\/jamaoncol.2015.2239","volume":"1","author":"CM Friedenreich","year":"2015","unstructured":"Friedenreich CM, Neilson HK, O\u2019Reilly R, Duha A, Yasui Y, Morielli AR, Adams SC, Courneya KS (2015) Effects of a high vs moderate volume of aerobic exercise on adiposity outcomes in postmenopausal women: a randomized clinical trial. JAMA Oncol 1(6):766\u2013776. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2239","journal-title":"JAMA Oncol"},{"key":"6092_CR67","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13058-015-0633-9","volume":"17","author":"WA van Gemert","year":"2015","unstructured":"van Gemert WA, Schuit AJ, van der Palen J, May AM, Iestra JA, Wittink H, Peeters PH, Monninkhof EM (2015) Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial. Breast Cancer Res 17:120. https:\/\/doi.org\/10.1186\/s13058-015-0633-9","journal-title":"Breast Cancer Res"},{"issue":"1","key":"6092_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00394-004-0487-x","volume":"44","author":"CA Thomson","year":"2005","unstructured":"Thomson CA, Rock CL, Giuliano AR, Newton TR, Cui H, Reid PM, Green TL, Alberts DS (2005) Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet. Eur J Nutr 44(1):18\u201325. https:\/\/doi.org\/10.1007\/s00394-004-0487-x","journal-title":"Eur J Nutr"},{"issue":"2","key":"6092_CR69","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/jcsm.12394","volume":"10","author":"DSM Ten Haaf","year":"2019","unstructured":"Ten Haaf DSM, Eijsvogels TMH, Bongers C, Horstman AMH, Timmers S, de Groot L, Hopman MTE (2019) Protein supplementation improves lean body mass in physically active older adults: a randomized placebo-controlled trial. J Cachexia Sarcopenia Muscle 10(2):298\u2013310. https:\/\/doi.org\/10.1002\/jcsm.12394","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"6092_CR70","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcn\/nqz120","volume":"110","author":"CJ Fuchs","year":"2019","unstructured":"Fuchs CJ, Hermans WJH, Holwerda AM, Smeets JSJ, Senden JM, van Kranenburg J, Gijsen AP, Wodzig W, Schierbeek H, Verdijk LB, van Loon LJC (2019) Branched-chain amino acid and branched-chain ketoacid ingestion increases muscle protein synthesis rates in vivo in older adults: a double-blind, randomized trial. Am J Clin Nutr 110(4):862\u2013872. https:\/\/doi.org\/10.1093\/ajcn\/nqz120","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"6092_CR71","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.clnu.2017.01.005","volume":"37","author":"S Verlaan","year":"2018","unstructured":"Verlaan S, Maier AB, Bauer JM, Bautmans I, Brandt K, Donini LM, Maggio M, McMurdo MET, Mets T, Seal C, Wijers SLJ, Sieber C, Boirie Y, Cederholm T (2018) Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults\u2014the PROVIDE study. Clin Nutr (Edinburgh, Scotland) 37(2):551\u2013557. https:\/\/doi.org\/10.1016\/j.clnu.2017.01.005","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"Suppl 3","key":"6092_CR72","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/s0960-9776(11)70291-0","volume":"20","author":"PJ Goodwin","year":"2011","unstructured":"Goodwin PJ, Stambolic V (2011) Obesity and insulin resistance in breast cancer\u2014chemoprevention strategies with a focus on metformin. Breast 20(Suppl 3):S31\u2013S35. https:\/\/doi.org\/10.1016\/s0960-9776(11)70291-0","journal-title":"Breast"},{"issue":"3","key":"6092_CR73","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1158\/1940-6207.Capr-16-0211-t","volume":"10","author":"LA Checkley","year":"2017","unstructured":"Checkley LA, Rudolph MC, Wellberg EA, Giles ED, Wahdan-Alaswad RS, Houck JA, Edgerton SM, Thor AD, Schedin P, Anderson SM, MacLean PS (2017) Metformin accumulation correlates with organic cation transporter 2 protein expression and predicts mammary tumor regression in vivo. Cancer Prev Res (Phila) 10(3):198\u2013207. https:\/\/doi.org\/10.1158\/1940-6207.Capr-16-0211-t","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7503","key":"6092_CR74","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304\u20131305. https:\/\/doi.org\/10.1136\/bmj.38415.708634.F7","journal-title":"BMJ"},{"issue":"3","key":"6092_CR75","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10549-011-1612-1","volume":"128","author":"S Hadad","year":"2011","unstructured":"Hadad S, Iwamoto T, Jordan L, Purdie C, Bray S, Baker L, Jellema G, Deharo S, Hardie DG, Pusztai L, Moulder-Thompson S, Dewar JA, Thompson AM (2011) Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat 128(3):783\u2013794. https:\/\/doi.org\/10.1007\/s10549-011-1612-1","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"6092_CR76","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10549-012-2223-1","volume":"135","author":"S Niraula","year":"2012","unstructured":"Niraula S, Dowling RJ, Ennis M, Chang MC, Done SJ, Hood N, Escallon J, Leong WL, McCready DR, Reedijk M, Stambolic V, Goodwin PJ (2012) Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study. Breast Cancer Res Treat 135(3):821\u2013830. https:\/\/doi.org\/10.1007\/s10549-012-2223-1","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"6092_CR77","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/07357907.2014.889706","volume":"32","author":"K Kalinsky","year":"2014","unstructured":"Kalinsky K, Crew KD, Refice S, Xiao T, Wang A, Feldman SM, Taback B, Ahmad A, Cremers S, Hibshoosh H, Maurer M, Hershman DL (2014) Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer. Cancer Investig 32(4):150\u2013157. https:\/\/doi.org\/10.3109\/07357907.2014.889706","journal-title":"Cancer Investig"},{"issue":"3","key":"6092_CR78","doi-asserted-by":"publisher","first-page":"djv006","DOI":"10.1093\/jnci\/djv006","volume":"107","author":"PJ Goodwin","year":"2015","unstructured":"Goodwin PJ, Parulekar WR, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, Mukherjee SD, Chalchal HI, Oja CD, Tonkin KS, Bernstein V, Chen BE, Stambolic V (2015) Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32. J Natl Cancer Inst 107(3):djv006. https:\/\/doi.org\/10.1093\/jnci\/djv006","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"6092_CR79","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1530\/eje-13-0406","volume":"169","author":"V Birzniece","year":"2013","unstructured":"Birzniece V, Umpleby MA, Poljak A, Handelsman DJ, Ho KK (2013) Oral low-dose testosterone administration induces whole-body protein anabolism in postmenopausal women: a novel liver-targeted therapy. Eur J Endocrinol 169(3):321\u2013327. https:\/\/doi.org\/10.1530\/eje-13-0406","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"6092_CR80","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/bcr3394","volume":"15","author":"RT Fortner","year":"2013","unstructured":"Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE (2013) Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses\u2019 Health Study II. Breast Cancer Res 15(2):R19. https:\/\/doi.org\/10.1186\/bcr3394","journal-title":"Breast Cancer Res"},{"issue":"8","key":"6092_CR81","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606\u2013616","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"6092_CR82","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1038\/onc.2016.432","volume":"36","author":"J Feng","year":"2017","unstructured":"Feng J, Li L, Zhang N, Liu J, Zhang L, Gao H, Wang G, Li Y, Zhang Y, Li X, Liu D, Lu J, Huang B (2017) Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms. Oncogene 36(20):2775\u20132790. https:\/\/doi.org\/10.1038\/onc.2016.432","journal-title":"Oncogene"},{"key":"6092_CR83","doi-asserted-by":"publisher","unstructured":"Su F, Ahn S, Saha A, DiGiovanni J, Kolonin MG (2018) Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance. Oncogene. https:\/\/doi.org\/10.1038\/s41388-018-0558-8","DOI":"10.1038\/s41388-018-0558-8"},{"key":"6092_CR84","unstructured":"Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement (1991) Am J Clin Nutr 9(1):1\u201320"},{"issue":"1","key":"6092_CR85","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/joim.12824","volume":"285","author":"DP Andersson","year":"2019","unstructured":"Andersson DP, Dahlman I, Eriksson Hogling D, Backdahl J, Toft E, Qvisth V, Naslund E, Thorell A, Ryden M, Arner P (2019) Improved metabolism and body composition beyond normal levels following gastric bypass surgery: a longitudinal study. J Intern Med 285(1):92\u2013101. https:\/\/doi.org\/10.1111\/joim.12824","journal-title":"J Intern Med"},{"key":"6092_CR86","doi-asserted-by":"publisher","unstructured":"Feigelson HS, Caan B, Weinmann S, Leonard AC, Powers JD, Yenumula PR, Arterburn DE, Koebnick C, Altaye M, Schauer DP (2019) Bariatric surgery is associated with reduced risk of breast cancer in both premenopausal and postmenopausal women. Ann Surg. https:\/\/doi.org\/10.1097\/sla.0000000000003331","DOI":"10.1097\/sla.0000000000003331"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-06092-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T13:26:42Z","timestamp":1616592402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-06092-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6092"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-06092-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"assertion":[{"value":"10 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}